Alnylam Pharmaceuticals, Inc. (BMV:ALNY)

Alnylam Pharmaceuticals Statistics

Total Valuation

BMV:ALNY has a market cap or net worth of MXN 1.09 trillion. The enterprise value is 1.09 trillion.

Market Cap	1.09T
Enterprise Value	1.09T

Important Dates

The next estimated earnings date is Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	131.08M
Shares Outstanding	n/a
Shares Change (YoY)	+2.84%
Shares Change (QoQ)	+0.73%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	126.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	75.61
PS Ratio	23.53
PB Ratio	231.19
P/TBV Ratio	231.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-181.20
EV / Sales	24.10
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1,110.03

Financial Position

The company has a current ratio of 2.80, with a Debt / Equity ratio of 10.93.

Current Ratio	2.80
Quick Ratio	2.63
Debt / Equity	10.93
Debt / EBITDA	n/a
Debt / FCF	-52.60
Interest Coverage	-1.18

Financial Efficiency

Return on equity (ROE) is -257.82% and return on invested capital (ROIC) is -3.95%.

Return on Equity (ROE)	-257.82%
Return on Assets (ROA)	-2.63%
Return on Invested Capital (ROIC)	-3.95%
Return on Capital Employed (ROCE)	-5.52%
Revenue Per Employee	20.82M
Profits Per Employee	-2.70M
Employee Count	2,230
Asset Turnover	0.57
Inventory Turnover	5.17

Taxes

Income Tax	-1.14B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +66.60% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+66.60%
50-Day Moving Average	3,821.82
200-Day Moving Average	n/a
Relative Strength Index (RSI)	76.36
Average Volume (20 Days)	344

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.48

Income Statement

In the last 12 months, BMV:ALNY had revenue of MXN 46.43 billion and -6.02 billion in losses. Loss per share was -46.46.

Revenue	46.43B
Gross Profit	38.83B
Operating Income	-3.40B
Pretax Income	-7.16B
Net Income	-6.02B
EBITDA	-2.33B
EBIT	-3.40B
Loss Per Share	-46.46

Balance Sheet

The company has 53.89 billion in cash and 51.67 billion in debt, giving a net cash position of 2.22 billion.

Cash & Cash Equivalents	53.89B
Total Debt	51.67B
Net Cash	2.22B
Net Cash Per Share	n/a
Equity (Book Value)	4.73B
Book Value Per Share	36.08
Working Capital	44.18B

Cash Flow

In the last 12 months, operating cash flow was -293.04 million and capital expenditures -689.25 million, giving a free cash flow of -982.29 million.

Operating Cash Flow	-293.04M
Capital Expenditures	-689.25M
Free Cash Flow	-982.29M
FCF Per Share	n/a

Margins

Gross margin is 83.64%, with operating and profit margins of -7.32% and -12.96%.

Gross Margin	83.64%
Operating Margin	-7.32%
Pretax Margin	-15.42%
Profit Margin	-12.96%
EBITDA Margin	-5.02%
EBIT Margin	-7.32%
FCF Margin	n/a

Dividends & Yields

BMV:ALNY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.84%
Shareholder Yield	n/a
Earnings Yield	-0.55%
FCF Yield	-0.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:ALNY has an Altman Z-Score of 3.49 and a Piotroski F-Score of 1.

Altman Z-Score	3.49
Piotroski F-Score	1